Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), sold 3,078,820 shares at $0.49 ($1.5M) on 2015-11-25, disclosed to the SEC on 2015-11-30.
Seasonal sale ($1.5M) by Director, 10% Owner — this insider has traded SNTA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.49 | 544,571 | $267K | 18.0% |
| 2 | $0.49 | 959,149 | $470K | 31.8% |
| 3 | $0.50 | 338,463 | $169K | 11.4% |
| 4 | $0.50 | 596,132 | $298K | 20.1% |
| 5 | $0.43 | 231,959 | $100K | 6.7% |
| 6 | $0.43 | 408,546 |
| $176K |
| 11.9% |
| Total | $0.48 avg | 3,078,820 | $1.5M | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |